Cargando…
Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model
Glioblastoma, the most aggressive form of glioma, has a 5-year survival rate of <5%. While radiation and immunotherapies are routinely studied in the murine Gl261 glioma model, little is known about its inherent immune response. This study quantifies the temporal and spatial localization of immun...
Autores principales: | McKelvey, Kelly J., Hudson, Amanda L., Prasanna Kumar, Ramyashree, Wilmott, James S., Attrill, Grace H., Long, Georgina V., Scolyer, Richard A., Clarke, Stephen J., Wheeler, Helen R., Diakos, Connie I., Howell, Viive M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117758/ https://www.ncbi.nlm.nih.gov/pubmed/32240177 http://dx.doi.org/10.1371/journal.pone.0226444 |
Ejemplares similares
-
Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer
por: McKelvey, Kelly J., et al.
Publicado: (2020) -
A therapeutic cancer vaccine against GL261 murine glioma
por: Kindy, Mark S., et al.
Publicado: (2016) -
Differential effects of radiation fractionation regimens on glioblastoma
por: McKelvey, Kelly J., et al.
Publicado: (2022) -
Anthracycline-induced cytotoxicity in the GL261 glioma model system
por: Tavener, Amber M., et al.
Publicado: (2021) -
Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells
por: Clark, Aaron J, et al.
Publicado: (2014)